A vlgt (Lgt, lipoprotein diacylglyceryl transferase) isogenic mutant was obtained which indicates that lgt is not essential for cell growth in vitro, like in the Gram-positive bacterium Bacillus subtilis, but unlike in the proteobacteria Escherichia coli and Salmonella typhimurium. The mutation was transduced to a virulent strain. A 5 log attenuation was observed in a respiratory tract model of infection. Metabolic labeling by [U-14 C]palmitate revealed the presence of eight to ten lipoproteins in the wild-type strain only, with molecular masses between 15 and 80 kDa. Our findings suggest a major difference in the role of lipoproteins in Gram-positive bacteria versus the proteobacteria. ß
Introduction
Streptococcus pneumoniae is one of the leading causes of septicemia, meningitis, and lower respiratory tract infections in humans. A better understanding of the cellular biochemistry of the pneumococci is essential for the development of novel antimicrobial therapeutics.
A key biochemical pathway is the lipid modi¢cation of proteins, which allows their localization to the bacterial cell surface. More than 150 bacterial lipoproteins of diverse structure and function have been identi¢ed to date. All lipoproteins have a characteristic lipobox sequence (commonly -Leu 33 -Ser/Ala 32 -Ala/Gly 31 -Cys 1 -) [1] . A common biosynthetic pathway for lipoproteins was proposed [2] , and subsequently modi¢ed [3] . The ¢rst step is the transfer of the diacylglyceryl moiety from phosphatidylglycerol to the sulfhydryl group of the prospective N-terminal cysteine residue in the unmodi¢ed prolipoprotein by prolipoprotein diacylglyceryl transferase (Lgt) with the concomitant formation of Sn-glycerol-1-phosphate.
Diacylglyceryl modi¢cation is a prerequisite for the cleavage of the signal peptide by a lipoprotein-speci¢c signal peptidase called signal peptidase II [4, 5] . The amino-terminal of the product, apolipoprotein, is further N-acylated by N-acyltransferase which has no speci¢city with respect to phospholipids as acyl donors [6, 7] .
This pathway appears to be essential in Escherichia coli and Salmonella typhimurium since mutants defective in the activity of any of these three enzymes are temperature sensitive in growth, suggesting that one or more lipoproteins are required for normal growth, division and viability [3,8^11] . Database searches indicate that the key enzyme in this pathway, Lgt, is present in a wide range of bacteria. However the biochemical function of Lgt in Gram-positive bacteria has been little studied. The presence of Lgt in important Gram-positive and Gram-negative human bacterial pathogens, in conjunction with the apparent absence of this protein in eukaryotes, suggests that Lgt might be a potential novel antimicrobial target.
In this study we constructed an isogenic vlgt mutant and compared it to the wild-type strain for in vitro growth and for virulence in a respiratory tract model of infection. We show that lgt is not essential for cell growth in vitro but is essential for viability during infection.
Materials and methods

Bacterial strains
The laboratory strain S. pneumoniae R6 [12] , and the virulent strain S. pneumoniae 0100993 (serotype 3) from GlaxoSmithKline's collection, were used in this study.
S. pneumoniae strains were routinely cultured in AGCH medium [13] modi¢ed by adding 0.3% (w/v) sucrose and 0.2% (w/v) yeast extract. For enumeration, TSA II (trypticase soy agar) agar plates containing 5% (w/v) sheep blood were used (Becton Dickinson, Franklin Lakes, NJ, USA). Erythromycin was added, when required, at a concentration of 1 ug ml 31 .
Allelic exchange mutagenesis
DNA fragments of 522 and 241 bp £anking lgt were fused to an erythromycin resistance determinant (ermAM) [14, 15] using crossover PCR [16] . The primers for the upstream £anker were 5P-TGGCAGAACGTACCAGTG-TGCACGGTG-3P and 5P-CCGCCATTCTTTGCTGTT-TCGTTTGCACCTCATTTCGAGCTATGAG-3P (the sequences in bold are the sequences complimentary to ermAM). The primers for the downstream £anker were 5P-GGAAAGTTACACACGTTACTAAAGGAGCTACC-GTCAACCGACTTTCC-3P and 5P-GATCATTATACC-GAGACCG-3P. These constructs were used to transform S. pneumoniae R6 by incubating 0.5 ug DNA with 10 6 bacterial cells at 30³C for 30 min in the presence of the Csp1 competence stimulating heptadecapeptide [17] . Cells were then incubated for a further 90 min at 37³C before plating on AGCH containing 1 ug erythromycin per ml. Transformants were assessed following growth at 37³C for 36 h in 5% (v/v) CO 2 . Transformation frequency with control DNA was 10 3 transformants per ug DNA. Chromosomal DNA was prepared from erythromycin-resistant transformants of S. pneumoniae R6 and used to transform the pathogenic S. pneumoniae strain 0100993 in the presence of Csp1 [17] . Transformants containing the appropriate allelic replacement were con¢rmed by Southern analysis (not shown).
In control experiments where S. pneumoniae 0100993 was transformed with chromosomal DNA from wildtype S. pneumoniae R6, no tranformants were obtained. S. pneumoniae 0100993 was also transformed with DNA from an allelic replacement mutant of malC in S. pneumoniae R6 at a frequency of 10 2 per Wg of DNA.
In vitro growth
The wt and the lgt deletion mutant strains of S. pneumoniae 0100993 were grown from stock solutions in 20 ml modi¢ed AGCH medium. The medium was inoculated with 1U10 6 CFU ml 31 of the respective strains. Aliquots were taken at time intervals and serial dilutions were plated on TSA II medium.
Respiratory tract infection
The experiment was carried out in duplicate, using ¢ve animals per experiment. Bacteria were prepared from frozen stocks by inoculation of TSA II plates. Following overnight growth at 37³C in 5% (v/v) CO 2 , bacteria were recovered from the plates, resuspended in phosphatebu¡erred saline (PBS) and adjusted to an OD 600 of 0.90. The male CBA/J mice (14^16 g) were lightly anaesthetized with 3% (v/v) iso£urane. 50 Wl of the inoculum, which corresponds to 1U10 6 CFU on average was delivered intranasally. Mice were then killed at 48 h post-inoculation by CO 2 overdose and lungs were aseptically removed and homogenized in 1 ml of PBS, using a Seward stomacher (Seward Ldt., London, UK). Viable bacteria were enumerated on TSA II plates.
Detection of lipoproteins
For the detection of lipoproteins, S. pneumoniae 0100993 was cultivated in brain heart infusion (BHI) medium to which 2 WCi [U-
14 C]palmitate was added. Cells were incubated for 5 h at 37³C. Cells were harvested, washed three times with 150 mM Tris^HCl, pH 8 bu¡er and resuspended in 100 Wl protoplast bu¡er (50 mM TrisĤ Cl, pH 8, 15 mM MgCl 2 , 66% (w/v) sucrose) containing 2.5 mg ml 31 of lyzozyme. The cell suspension was incubated for 1 h at 37³C. The proteins were solubilized by adding 100 Wl of SDS extraction bu¡er (1.1 M sucrose, 500 mM Tris^HCl, 278 mM sodium dodecyl sulfate (SDS), 2 mM EDTA, 0.9 mM Serva Blue G250, pH 8.5) and boiling the samples for 10 min. 20 Wl of each sample was subjected to electrophoresis. Proteins were transferred to a PVDF membrane and detected by autoradiography.
Results
In vitro growth
The wt and the lgt deletion mutant strains of S. pneumoniae 0100993 were grown in modi¢ed AGCH medium from stock solutions. 20 ml of fresh modi¢ed AGCH medium was inoculated to reach a cell concentration of approximately 1U10 6 CFU ml 31 and was incubated at 37³C. Growth was recorded by measuring absorbance at 600 nm at time intervals. No di¡erence was observed between the two strains. A doubling time of 45 min for both strains was achieved during logarithmic phase. Furthermore, for both strains a population of 2U10 8 CFU ml 31 was estimated after 6 h of incubation and before both strains entered the cell lysis stage commonly observed when growing S. pneumoniae (data not shown). As further evidence, another experiment was carried out for which growth was recorded during three passages. For the ¢rst passage, 20 ml of medium was inoculated as described above. When the culture reached an OD 600 of 0.3 (mid-logarithmic phase), 200 ul of the culture was inoculated to 20 ml of fresh medium. This was repeated twice. The ¢nal culture was monitored until the end of the logarithmic phase. Again, no di¡erences were recorded (Fig. 1) , indicating that the viability of the wt and lgt mutant strains is similar in vitro.
Respiratory tract infection
To further ascertain the potential e¡ect of a deletion in the lgt gene, in vivo studies were carried out. The animals were infected with 1U10 6 CFU per animal on average. The number of bacteria recovered after infection was 6.3U10 7 CFU/lungs when animals were infected with the wt strain while it was below the limit of detection for four mice, and below 1U10 4 CFU/lungs for one mouse when animals were infected with the lgt deleted mutant (Fig. 2) . In the second set of experiments, the number was below the limit of detection for the ¢ve mice (data not shown) while 1.0U10 8 CFU/lungs were recovered from the control experiment. These results indicate that the mutant is largely attenuated during respiratory tract infection.
Lipoprotein pro¢le
SDS^PAGE pro¢le of [U-
14 C]palmitate-labeled proteins extracted from S. pneumoniae 0100993 cells revealed the presence of eight to ten lipoproteins, with sizes ranging from approximatively 15 to 80 kDa, and with variable intensity. No radiolabeled proteins were detected in the vlgt mutant strain, thus con¢rming the inactivation of this gene (Fig. 3) .
Discussion
Covalent modi¢cation of a cysteine residue with a glyceride thioester group was ¢rst described by Hantke and 4) . A control experiment in which proteins were detected by SDSP AGE followed by Coomassie staining was carried out to ensure equal loading (data not shown).
Braun [18] for the major outer membrane protein (Lpp) of E. coli. Since then, a substantial number of proteins considered to be lipoproteins have been identi¢ed in both Gram-positive and Gram-negative bacteria, directly from biochemical studies or indirectly from sequence analysis. These are less abundant than the Braun lipoprotein, but similar in structure [19] . Sutcli¡e and Russell [20] emphasized the role of lipid modi¢cation of proteins in cell surface localization in Gram-positive bacteria. For example, some L-lactamases in Bacillus licheniformis and Staphylococcus aureus have been shown to be membrane-associated lipoproteins. Also, some lipoproteins could act as substrate-binding molecules involved in transport systems or in chemoreception and sensory mechanisms. Some adhesins in Streptococcus sanguis, S. pneumoniae and Streptococcus gordonii were also reported to be lipoproteins. Considering that the three enzymes involved in this pathway, namely Lgt (prolipoprotein diacylglyceryl transferase), Lsp (prolipoprotein signal peptidase) and Lnt (apolipoprotein N-acyltransferase), appear to be essential in E. coli and S. typhimurium [3] , we decided to evaluate the essentiality of the lgt gene/protein in the pathogenic Gram-positive bacterium S. pneumoniae.
The lack of homogeneous enzyme preparations has precluded further biochemical characterization of Lgt. Our attempts to overexpress S. pneumoniae lgt were unsuccessful, as were our attempts to assay Lgt activity in vitro as described by Sankaran and Wu [3] and Gan et al. [21] . The results presented here indicate that Lgt is not an essential enzyme in S. pneumoniae, since lack of this enzyme does not result in cell death. In agreement with our results, recent studies indicated that lgt is not essential for growth in Bacillus subtilis [22] . The authors showed that a disruption in lgt completely abolished lipomodi¢cation of prelipoproteins, such as PrsA (foldase involved in protein secretion) and BlaP (penicillinase), but that B. subtilis cells were still fully viable. The lgt mutation in S. pneumoniae R6 was transformed into the virulent strain 0100993, and both the wild-type strain and the transformant were compared for in vivo growth in a respiratory tract model of infection. The full attenuation observed would suggest that lgt is essential for S. pneumoniae to establish and survive infection. A search of GlaxoSmithKline proprietary protein sequence database of S. pneumoniae 0100993 revealed the presence of 17 proteins with a lipobox motif near the extreme N-terminus (Table 1 ). These included proteins homologous to S. pneumoniae AmiA-AliA-AliB oligopeptide transporter [20] , Enterococcus faecalis D-alanyl-D-alanine carboxypeptidase, and proteins of unknown function from Haemophilus in£uenzae and B. subtilis. Interestingly, the search also identi¢ed PsaA, a known lipoprotein in S. pneumoniae involved in adhesion [23] and AdcA. For psaA, Berry and Paton [23] showed that two independent mutants were signi¢cantly less virulent as judged by intranasal or intraperitoneal challenge of mice than the wild-type. The AdcA protein was found to exhibit homology to ATP-binding cassette (ABC) transport operons encoding streptococcal adhesins such as FimA in Streptococcus parasanguis and ScaA in S. gordonii [24] . The PsaA and AdcA prelipoproteins have molecular masses of 34.6 and 56.2 kDa, respectively. The pattern of lipoproteins observed after in vivo labeling by [U- 14 C]palmitate indicated the presence of two bands migrating close to the 30 kDa marker and between the 46 and 66 kDa markers (Fig. 3) . These bands could correspond to the mature PsaA and AdcA lipoproteins for which we estimated the molecular mass at 33 and 55 kDa, respectively. From this work, it is clear that the role(s) of lipoproteins in Gram-positive bacteria and the proteobacteria is (are) di¡erent. This was ¢rst demonstrated in the nonpathogenic bacterium B. subtilis and is con¢rmed herein for the human pathogen S. pneumoniae. Nevertheless, our ¢ndings suggest that despite its non-essential nature for growth in vitro, the lgt gene is essential for the bacterium to establish and survive infection. This further supports Lgt as an attractive and broad spectrum antibacterial target.
